N/A N=12 Medtronic MiniMed Implantable Insulin Pump
Type 1 Diabetes
Primary: Glucose Control as Assessed by Mean Glucose Levels
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=77 A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
Premature Ejaculation
Primary: Mean Intravaginal Ejaculatory Latency Time (IELT) Compared Over All 8 Weeks of Treatment or Until Premature Discontinuation — 0.62; 0.72; 0.69; 0.71 minutes — p=0.4959
Phase 2 N=9 Investigation of Naltrexone for Pathological Gambling
Pathological Gambling
Primary: Yale Brown Obsessive Compulsive Scale Modified for Pathological Gambling (YBOCS-PG) — 16.0; 17.0; 10.0; 4.0 units on a scale
Phase 2 N=18 Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer
HER2-positive Breast Cancer · Stage II Breast Cancer · Stage IIIA Breast Cancer
Primary: Expression of ALDH1 and CD44v Change in the Binary Biomarkers From Baseline to 6 Weeks and 18 Weeks — 5; 3; 0; 4 Participants
Phase 2 N=113 Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection
Shigellosis
Primary: Post-challenge Diarrhea, Fever, and Blood in Stool Adverse Events by Study Group — 1; 0; 4; 4 participants
Phase 4 N=59 Desvenlafaxine vs. Placebo Treatment of Chronic Depression
Dysthymic Disorder · Dysthymia · Chronic Depressive Disorder
Primary: Hamilton Rating Scale for Depression (HDRS24) — 14.63; 14.21 units on a scale — p=0.09
N/A N=26 Racial Differences in Phosphorus Metabolism
Control
Primary: Urinary Phosphorus Excretion — 11 percentage of fractional excretion
Phase 3 N=444 A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Type 2 Diabetes
Primary: Adjusted Mean Change From Baseline in Hemoglobin A1C (HbA1c) at Week 24 (Last Observation Carried Forward [LOCF]) — -0.23; -0.82; -0.85 % of hemoglobin — p=<0.0001
Phase 2 N=24 Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)
PCV · Polypoidal Choroidal Vasculopathy
Primary: BCVA — -3.50; 29.50; 8.60 number of letters read correctly
N/A N=92 Differences in Morbidity Between a Necessity Endotracheal Suctioning Protocol Versus a Routine Endotracheal Suctioning
Hypoxemia · Arrhythmias · Cardiac Arrest
Primary: Primary Composite End Point — 35; 48 event
Phase 2 N=26 Effects of Aripiprazole on Cocaine Craving and Self-Administration
Cocaine Abuse
Primary: Cocaine Self-administration — 0; 1.5; 3; 4 Number of Choices
Phase 2 N=337 Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Pelvic Organ Prolapse
Primary: Number of Participants With Treatment Failure Defined as Subsequent Treatment for Urinary Incontinence, Signs or Symptoms of Bothersome Urinary Incontinence — 39; 85…
Phase 2 N=55 Antiplatelet Therapy in HIV
HIV · Cardiovascular Diseases · Inflammation
Primary: Percentage Platelet Aggregation in PRP After Stimulation With Arachidonic Acid 1600 μM for 5 Min — 72.35; 79.11; 72.79; 26.77 %aggregation
Phase 2 N=95 Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
Liver Cancer
Primary: Overall Survival — 8.55; 8.55 Months
Phase 3 N=26 Lateral Canthal Rhytides With Medium Depth Chemical Peel With or Without Pretreatment With Botulinum Toxin A
Wrinkles
Primary: Posttreament Results of Chemical Peel if Botox A is Added as Pre-treatment — 1; 2 Units on a wrinkle severity scale — p=.002